1. WellCare Health Plans, Inc. (WCG): Provides managed care services for government-sponsored healthcare programs in the United States. Market cap of $2.45B. In Dec 2010: Reported EPS at 0.71 vs. estimate at 0.52 (surprise of 36.5%). In Mar 2011: Reported EPS at 0.66 vs. estimate at 0.16 (surprise of 312.5%). In Jun 2011: Reported EPS at 1.77 vs. estimate at 0.95 (surprise of 86.3%). In Sep 2011: Reported 2.15 vs. estimate at 1.31 (surprise of 64.1%). [Average earnings surprise at 124.85%]. The stock has had a couple of great days, gaining 7.22% over the last week.
2. Vertex Pharmaceuticals Incorporated (VRTX): Engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Market cap of $7.73B. In Dec 2010: Reported EPS at -0.9 vs. estimate at -0.93 (surprise of 3.2%). In Mar 2011: Reported EPS at -0.87 vs. estimate at -1.09 (surprise of 20.2%). In Jun 2011: Reported EPS at -0.85 vs. estimate at -0.96 (surprise of 11.5%). In Sep 2011: Reported 1.02 vs. estimate at 0.21 (surprise of 385.7%). [Average earnings surprise at 105.15%]. The stock has had a couple of great days, gaining 11.93% over the last week.
3. Boston Scientific Corporation (BSX): Develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Market cap of $8.24B. In Dec 2010: Reported EPS at 0.12 vs. estimate at 0.1 (surprise of 20%). In Mar 2011: Reported EPS at 0.14 vs. estimate at 0.04 (surprise of 250%). In Jun 2011: Reported EPS at 0.12 vs. estimate at 0.09 (surprise of 33.3%). In Sep 2011: Reported 0.1 vs. estimate at 0.08 (surprise of 25%). [Average earnings surprise at 82.08%]. The stock has lost 25.27% over the last year.
4. Akorn, Inc. (AKRX): Engages in the manufacture and marketing of diagnostic and therapeutic pharmaceutical products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. Market cap of $1.02B. In Dec 2010: Reported EPS at 0.08 vs. estimate at 0.04 (surprise of 100%). In Mar 2011: Reported EPS at 0.07 vs. estimate at 0.05 (surprise of 40%). In Jun 2011: Reported EPS at 0.08 vs. estimate at 0.05 (surprise of 60%). In Sep 2011: Reported 0.09 vs. estimate at 0.07 (surprise of 28.6%. [Average earnings surprise at 57.15%]. The stock has gained 86.14% over the last year.
5. OraSure Technologies Inc. (OSUR): Develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. Market cap of $469.37M. In Dec 2010: Reported EPS at -0.02 vs. estimate at -0.08 (surprise of 75%). In Mar 2011: Reported EPS at -0.06 vs. estimate at -0.08 (surprise of 25%). In Jun 2011: Reported EPS at -0.05 vs. estimate at -0.07 (surprise of 28.6%). In Sep 2011: Reported -0.03 vs. estimate at -0.07 (surprise of 57.1%. [Average earnings surprise at 46.42%]. The stock is a short squeeze candidate, with a short float at 5.45% (equivalent to 11.06 days of average volume). The stock has gained 48.58% over the last year.
6. Salix Pharmaceuticals Ltd. (SLXP): Develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. Market cap of $2.92B. In Dec 2010: Reported EPS at 0.66 vs. estimate at 0.49 (surprise of 34.7%). In Mar 2011: Reported EPS at 0.34 vs. estimate at 0.17 (surprise of 100%). In Jun 2011: Reported EPS at 0.54 vs. estimate at 0.49 (surprise of 10.2%). In Sep 2011: Reported 0.77 vs. estimate at 0.63 (surprise of 22.2%). [Average earnings surprise at 41.78%]. The stock is a short squeeze candidate, with a short float at 12.13% (equivalent to 7.63 days of average volume). The stock has had a good month, gaining 11.6%.
7. Synovis Life Technologies Inc. (SYNO): Develops, manufactures, and markets mechanical and biological products used by surgical specialties for the repair of soft tissue damaged or destroyed by disease or injury. Market cap of $311.75M. In Jan 2011: Reported EPS at 0.16 vs. estimate at 0.1 (surprise of 60%). In Apr 2011: Reported EPS at 0.17 vs. estimate at 0.14 (surprise of 21.4%). In Jul 2011: Reported EPS at 0.17 vs. estimate at 0.15 (surprise of 13.3%). In Oct 2011: Reported 0.24 vs. estimate at 0.18 (surprise of 33.3%). [Average earnings surprise at 32%]. The stock has had a good month, gaining 51.36%.
8. Hi Tech Pharmacal Co. Inc. (HITK): Develops, manufactures, markets, and sells generic, prescription, over-the-counter, and nutritional products in liquid and semisolid dosage forms in the United States. Market cap of $455.56M. In Jan 2011: Reported EPS at 0.79 vs. estimate at 0.63 (surprise of 25.4%). In Apr 2011: Reported EPS at 0.98 vs. estimate at 0.71 (surprise of 38%). In Jul 2011: Reported EPS at 1.05 vs. estimate at 0.84 (surprise of 25%). In Oct 2011: Reported 1.04 vs. estimate at 0.77 (surprise of 35.1%). [Average earnings surprise at 30.87%]. The stock is a short squeeze candidate, with a short float at 14.11% (equivalent to 5.97 days of average volume). The stock has gained 39.83% over the last year.
9. Impax Laboratories Inc. (IPXL): Engages in the development, manufacture, and marketing of bioequivalent pharmaceutical products. Market cap of $1.32B. In Dec 2010: Reported EPS at 0.23 vs. estimate at 0.22 (surprise of 4.5%). In Mar 2011: Reported EPS at 0.24 vs. estimate at 0.15 (surprise of 60%). In Jun 2011: Reported EPS at 0.22 vs. estimate at 0.19 (surprise of 15.8%). In Sep 2011: Reported 0.3 vs. estimate at 0.23 (surprise of 30.4%). [Average earnings surprise at 27.68%]. The stock is a short squeeze candidate, with a short float at 6.49% (equivalent to 7.15 days of average volume). The stock has lost 3.77% over the last year.
10. Kindred Healthcare Inc. (KND): Operates as a healthcare services company in the United States. Market cap of $547.26M. In Dec 2010: Reported EPS at 0.54 vs. estimate at 0.44 (surprise of 22.7%). In Mar 2011: Reported EPS at 0.65 vs. estimate at 0.48 (surprise of 35.4%). In Jun 2011: Reported EPS at 0.53 vs. estimate at 0.51 (surprise of 3.9%). In Sep 2011: Reported 0.41 vs. estimate at 0.29 (surprise of 41.4%). [Average earnings surprise at 25.85%]. The stock is a short squeeze candidate, with a short float at 13.49% (equivalent to 7.23 days of average volume). It's been a rough couple of days for the stock, losing 6.08% over the last week.
11. Aetna Inc. (AET): Operates as a diversified health care benefits company in the United States. Market cap of $15.92B. In Dec 2010: Reported EPS at 0.63 vs. estimate at 0.62 (surprise of 1.6%). In Mar 2011: Reported EPS at 1.43 vs. estimate at 0.97 (surprise of 47.4%). In Jun 2011: Reported EPS at 1.35 vs. estimate at 1.08 (surprise of 25%). In Sep 2011: Reported 1.4 vs. estimate at 1.15 (surprise of 21.7%). [Average earnings surprise at 23.92%]. Might be undervalued at current levels, with a PEG ratio at 0.77, and P/FCF ratio at 7.21. The stock has had a good month, gaining 10.21%.
12. Unitedhealth Group, Inc. (UNH): Provides healthcare services in the United States. Market cap of $56.36B. In Dec 2010: Reported EPS at 1.05 vs. estimate at 0.84 (surprise of 25%). In Mar 2011: Reported EPS at 1.22 vs. estimate at 0.89 (surprise of 37.1%). In Jun 2011: Reported EPS at 1.16 vs. estimate at 0.94 (surprise of 23.4%). In Sep 2011: Reported 1.17 vs. estimate at 1.12 (surprise of 4.5%). [Average earnings surprise at 22.5%]. The stock has gained 37.83% over the last year.
13. ICU Medical, Inc. (ICUI): Engages in the development, manufacture, and sale of disposable medical connection systems for use in vascular therapy applications in the United States and internationally. Market cap of $618.89M. In Dec 2010: Reported EPS at 0.72 vs. estimate at 0.53 (surprise of 35.8%). In Mar 2011: Reported EPS at 0.57 vs. estimate at 0.47 (surprise of 21.3%). In Jun 2011: Reported EPS at 0.67 vs. estimate at 0.56 (surprise of 19.6%). In Sep 2011: Reported 0.65 vs. estimate at 0.58 (surprise of 12.1%). [Average earnings surprise at 22.2%]. The stock is a short squeeze candidate, with a short float at 17.72% (equivalent to 33.05 days of average volume). The stock has gained 23.07% over the last year.
14. Magellan Health Services Inc. (MGLN): Provides managed behavioral healthcare, radiology benefits management, specialty pharmaceutical management, and Medicaid administration products and services in the United States. Market cap of $1.42B. In Dec 2010: Reported EPS at 0.95 vs. estimate at 0.91 (surprise of 4.4%). In Mar 2011: Reported EPS at 1.02 vs. estimate at 0.79 (surprise of 29.1%). In Jun 2011: Reported EPS at 1.07 vs. estimate at 0.86 (surprise of 24.4%). In Sep 2011: Reported 1.03 vs. estimate at 0.84 (surprise of 22.6%). [Average earnings surprise at 20.12%]. The stock has lost 0.34% over the last year.
15. Orthofix International N.V. (OFIX): Designs, develops, manufactures, markets, and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. Market cap of $705.10M. In Dec 2010: Reported EPS at 0.67 vs. estimate at 0.41 (surprise of 63.4%). In Mar 2011: Reported EPS at 0.56 vs. estimate at 0.55 (surprise of 1.8%). In Jun 2011: Reported EPS at 0.69 vs. estimate at 0.63 (surprise of 9.5%). In Sep 2011: Reported 0.67 vs. estimate at 0.65 (surprise of 3.1%). [Average earnings surprise at 19.45%]. The stock has had a couple of great days, gaining 10.47% over the last week.
16. HealthSpring Inc. (HS): Operates as a managed care organization in the United States. Market cap of $3.71B. In Dec 2010: Reported EPS at 0.89 vs. estimate at 0.77 (surprise of 15.6%). In Mar 2011: Reported EPS at 0.75 vs. estimate at 0.59 (surprise of 27.1%). In Jun 2011: Reported EPS at 1.23 vs. estimate at 0.95 (surprise of 29.5%). In Sep 2011: Reported 1.16 vs. estimate at 1.13 (surprise of 2.7%). [Average earnings surprise at 18.72%]. The stock has gained 79.54% over the last year.
17. ZOLL Medical Corp. (ZOLL): Develops, manufactures, and markets resuscitation devices and related software solutions worldwide. Market cap of $1.51B. In Dec 2010: Reported EPS at 0.18 vs. estimate at 0.16 (surprise of 12.5%). In Mar 2011: Reported EPS at 0.27 vs. estimate at 0.2 (surprise of 35%). In Jun 2011: Reported EPS at 0.42 vs. estimate at 0.35 (surprise of 20%). In Sep 2011: Reported 0.52 vs. estimate at 0.49 (surprise of 6.1%). [Average earnings surprise at 18.4%]. Exhibiting strong upside momentum--currently trading 5.68% above its SMA20, 33.93% above its SMA50, and 35.85% above its SMA200. The stock has had a couple of great days, gaining 5.77% over the last week.
18. Herbalife Ltd. (HLF): Sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. Market cap of $6.46B. In Dec 2010: Reported EPS at 0.66 vs. estimate at 0.56 (surprise of 17.9%). In Mar 2011: Reported EPS at 0.72 vs. estimate at 0.6 (surprise of 20%). In Jun 2011: Reported EPS at 0.88 vs. estimate at 0.75 (surprise of 17.3%). In Sep 2011: Reported 0.87 vs. estimate at 0.76 (surprise of 14.5%). [Average earnings surprise at 17.42%]. The stock has had a couple of great days, gaining 8.43% over the last week.
*Earnings data sourced from Yahoo! Finance, all other data sourced from Finviz.For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment